Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
24.0%
% of FTXH's 51 holdings also in PPH
50.0%
% of PPH's 27 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 6.9% | 6.4% | 6.4% |
|
MERCK & CO. INC. | 7.6% | 6.2% | 6.2% |
|
ABBVIE INC | 6.8% | 5.4% | 5.4% |
|
PFIZER INC | 7.8% | 4.7% | 4.7% |
|
BRISTOL-MYERS SQUIBB CO | 6.5% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PPH
|
AMGEN INC | 4.2% |
|
UNITED THERAPEUTICS CORP | 3.9% |
|
BIOGEN IDEC INC | 3.8% |
|
REGENERON PHARMACEUTICALS | 3.7% |
|
VERTEX PHARMACEUTICALS INC | 3.7% |
|
GILEAD SCIENCES INC | 3.4% |
|
CARDINAL HEALTH INC | 3.3% |
|
PFIZER INC | 3.1% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% |
|
ORGANON & CO. | 2.3% |
FTXH Underweight Relative to PPH
 |
NOVO-NORDISK A/S-SPONS ADR | -9.6% |
|
ELI LILLY & CO | -7.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.9% |
 |
NOVARTIS AG-ADR | -5.0% |
|
MCKESSON CORP | -4.8% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -4.8% |
 |
SANOFI-AVENTIS-ADR | -4.7% |
|
AMERISOURCEBERGEN CORP | -4.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -4.1% |
 |
TEVA PHARMACEUTICAL-SP ADR | -3.3% |